Medication use in pregnancy: a cross-sectional, multinational web-based study
- PMID: 24534260
- PMCID: PMC3927801
- DOI: 10.1136/bmjopen-2013-004365
Medication use in pregnancy: a cross-sectional, multinational web-based study
Abstract
Objectives: Intercountry comparability between studies on medication use in pregnancy is difficult due to dissimilarities in study design and methodology. This study aimed to examine patterns and factors associated with medications use in pregnancy from a multinational perspective, with emphasis on type of medication utilised and indication for use.
Design: Cross-sectional, web-based study performed within the period from 1 October 2011 to 29 February 2012. Uniform collection of drug utilisation data was performed via an anonymous online questionnaire.
Setting: Multinational study in Europe (Western, Northern and Eastern), North and South America and Australia.
Participants: Pregnant women and new mothers with children less than 1 year of age.
Primary and secondary outcome measures: Prevalence of and factors associated with medication use for acute/short-term illnesses, chronic/long-term disorders and over-the-counter (OTC) medication use.
Results: The study population included 9459 women, of which 81.2% reported use of at least one medication (prescribed or OTC) during pregnancy. Overall, OTC medication use occurred in 66.9% of the pregnancies, whereas 68.4% and 17% of women reported use of at least one medication for treatment of acute/short-term illnesses and chronic/long-term disorders, respectively. The extent of self-reported medicated illnesses and types of medication used by indication varied across regions, especially in relation to urinary tract infections, depression or OTC nasal sprays. Women with higher age or lower educational level, housewives or women with an unplanned pregnancy were those most often reporting use of medication for chronic/long-term disorders. Immigrant women in Western (adjusted OR (aOR): 0.55, 95% CI 0.34 to 0.87) and Northern Europe (aOR: 0.50, 95% CI 0.31 to 0.83) were less likely to report use of medication for chronic/long-term disorders during pregnancy than non-immigrants.
Conclusions: In this study, the majority of women in Europe, North America, South America and Australia used at least one medication during pregnancy. There was a substantial inter-region variability in the types of medication used.
Keywords: Maternal medicine < OBSTETRICS; Public Health; Therapeutics.
Figures
Similar articles
-
Factors associated with the need for information about medicines among pregnant women - a multinational internet-based survey.Res Social Adm Pharm. 2015 Mar-Apr;11(2):297-302. doi: 10.1016/j.sapharm.2014.06.003. Epub 2014 Jun 21. Res Social Adm Pharm. 2015. PMID: 25096599
-
Characteristics of women who continue smoking during pregnancy: a cross-sectional study of pregnant women and new mothers in 15 European countries.BMC Pregnancy Childbirth. 2014 Jun 25;14:213. doi: 10.1186/1471-2393-14-213. BMC Pregnancy Childbirth. 2014. PMID: 24964728 Free PMC article.
-
Predictors of the use of medications before and during pregnancy.Int J Clin Pharm. 2013 Jun;35(3):408-16. doi: 10.1007/s11096-013-9750-7. Epub 2013 Feb 7. Int J Clin Pharm. 2013. PMID: 23386140
-
Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG) : The use of medicines during pregnancy: call for action.Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:211-4. doi: 10.1016/j.ejogrb.2016.04.016. Epub 2016 Apr 25. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 27132708 Review.
-
Over the Counter Products for Acne Treatment and Maintenance in Latin America: A Review of Current Clinical Practice.J Drugs Dermatol. 2021 Mar 1;20(3):244-250. doi: 10.36849/JDD.5779. J Drugs Dermatol. 2021. PMID: 33683089 Review.
Cited by
-
Knowledge and practice of community pharmacists regarding the safety of drugs during pregnancy: a cross-sectional study from a developing country.BMC Pregnancy Childbirth. 2024 Mar 11;24(1):189. doi: 10.1186/s12884-024-06393-3. BMC Pregnancy Childbirth. 2024. PMID: 38468217
-
How the structural determinants of health inequities impact access to prescription medication for pregnant women in Australia: a narrative review.Lancet Reg Health West Pac. 2023 Oct 10;42:100934. doi: 10.1016/j.lanwpc.2023.100934. eCollection 2024 Jan. Lancet Reg Health West Pac. 2023. PMID: 38357390 Free PMC article. Review.
-
Building a Sustainable Learning Health Care System for Pregnant and Lactating People: Interview Study Among Data Access Providers.JMIR Pediatr Parent. 2024 Feb 8;7:e47092. doi: 10.2196/47092. JMIR Pediatr Parent. 2024. PMID: 38329780 Free PMC article.
-
Editorial: Long term effects of prenatal exposure to medications and vaccines.Front Pharmacol. 2024 Jan 19;15:1359539. doi: 10.3389/fphar.2024.1359539. eCollection 2024. Front Pharmacol. 2024. PMID: 38313310 Free PMC article. No abstract available.
-
Partner support for women's antidepressant treatment and its association with depressive symptoms in pregnant women, mothers, and women planning pregnancy.Arch Womens Ment Health. 2024 Feb 2. doi: 10.1007/s00737-024-01435-3. Online ahead of print. Arch Womens Ment Health. 2024. PMID: 38305896
References
-
- Committee on Ethics, American College of Obstetricians and Gynecologists ACOG Committee Opinion No. 377: research involving women. Obstet Gynecol 2007;110:731–6 - PubMed
-
- Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet 2011;157:175–82 - PubMed
-
- Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. [S.l]: Lippincott Williams & Wilkins, 2011
-
- Odalovic M, Vezmar Kovacevic S, Ilic K, et al. Drug use before and during pregnancy in Serbia. Int J Clin Pharm 2012;34:719–27 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical